Dudediligence.

Imunon, Inc

IMNNNASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Material agreementSep 29 →InsidersNo open-market buys or sales.→HoldersArmistice Capital 3.1%Riverview Capital 0.7%Vanguard 1.0%→Financing →PeersClosest companies: KTTA, ATNM, CLRB→

From the filings

Figures

Net income
$14.3Mlast 12 months
Operating cash flow
−$15.0Mlast 12 months
Cash and equivalents
$6.9Mat the last balance sheet
Shares outstanding
4.7M shareson issue
Every year and quarter →